1. Home
  2. IPDN vs ACXP Comparison

IPDN vs ACXP Comparison

Compare IPDN & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Professional Diversity Network Inc.

IPDN

Professional Diversity Network Inc.

BUY

Current Price

$4.30

Market Cap

6.6M

Sector

Technology

ML Signal

BUY

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

SELL

Current Price

$1.25

Market Cap

6.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IPDN
ACXP
Founded
2003
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
6.2M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
IPDN
ACXP
Price
$4.30
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
★ 15.6M
85.9K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $22,054,219.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.10
$1.23
52 Week High
$7.70
$7.98

Technical Indicators

Market Signals
Indicator
IPDN
ACXP
Relative Strength Index (RSI) 63.68 35.81
Support Level $0.64 $1.23
Resistance Level $7.70 $1.46
Average True Range (ATR) 1.03 0.06
MACD -0.03 -0.00
Stochastic Oscillator 29.89 15.85

Price Performance

Historical Comparison
IPDN
ACXP

About IPDN Professional Diversity Network Inc.

Professional Diversity Network Inc provides access to networking, training, educational, and employment services to its registered users. It has three operating segments: the TalentAlly Network segment, which maintains and operates job board software and hosts career fairs; the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization; the RemoteMore segment; and Corporate Overhead. The company generates the majority of its revenue from the TalentAlly Network Segment.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: